Publications

Journal Article
Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.
Ppublish 121 citations
Electronic publication date
April 1, 1995

View on Pubmed.gov 7533855 | View on doi.org 10.1128/JVI.69....

Optimal lymphocytic choriomeningitis virus sequences restricted by H-2Db major histocompatibility complex class I molecules and presented to cytotoxic T lymphocytes.

Search for publications in this journal J Virol - 69(4):2297-305

Abstract

Infection with lymphocytic choriomeningitis virus induces the generation of CD8+ cytotoxic T lymphocytes (CTL). In the H-2b mouse, this cellular immune response is directed against three viral structural epitopes (GP1, GP2, and NP) presented by the major histocompatibility complex (MHC) class I H-2Db molecules. This study was undertaken to delineate which sequence of each of these three epitopes is optimal for MHC binding and CTL recognition. The first step was to synthesize the relevant peptides truncated at the N or C terminus and flanking the crucial H-2Db-anchoring Asn residue in position 5. These peptides were then tested (i) for their binding properties in two H-2Db-specific assays with viable cells (upregulation of H-2Db expression on the surface of RMA-S cells and competition against the Db-restricted peptide 125I-gp276-286 on T2-Db cells) and (ii) for their abilities to sensitize H-2b target cells for CTL lysis in vitro. For optimal antigenic presentation, all three epitopes required the MHC-anchoring Asn residue at position 5 of their sequences. The results clearly and unambiguously delineated optimal lengths for two of the epitopes and two options for the third. NP appeared as a conventional 9-amino-acid (aa)-long peptide, np396-404 (FQPQNGQFI). GP2 was defined as a longer peptide (11 aa), gp276-286 (SGVENPGGYCL). Characterization of the GP1 epitope was more complex: the 9-aa-long peptide gp33-41 (KAVYNFATC) and the carboxyl-extended 11-aa-long peptide gp33-43 (KAVYN FATCGI) were both established as possible optimal sequences depending on the cell line used to test binding and lysis.

References

Nature. 1992 Nov 26;360(6402):364-6

J Immunol. 1984 Jul;133(1):433-9

Immunogenetics. 1985;21(3):235-46

Cell. 1992 Sep 18;70(6):1035-48

Cited by 121 citations (total)

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Viral infection of transgenic mice expressing a viral protein in oligodendrocytes leads to chronic central nervous system autoimmune disease.

Electronic publication date December 1, 1996

Search for publications in this journal J Exp Med

C F Evans [...] M B Oldstone et al.

One hypothesis for the etiology of central nervous system (CNS) autoimmune disease is that infection by a virus sharing antigenic...

Journal Article Research Support, Non-U.S. Gov't

Bone marrow-derived antigen-presenting cells are required for the generation of cytotoxic T lymphocyte responses to viruses and use transporter associated with antigen presentation (TAP)-dependent and -independent pathways of antigen presentation.

Electronic publication date February 28, 2001

Search for publications in this journal J Exp Med

L J Sigal [...] K L Rock et al.

Bone marrow (BM)-derived professional antigen-presenting cells (pAPCs) are required for the generation of cytotoxic T lymphocyte (CTL) responses to vaccinia...

Conflict of interest statement

No conflict of interest statement provided.

MeSH

Specialties

Substances